Aspirin use and bleeding risk in brain aneurysm surgery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at the risks of bleeding during and after brain aneurysm surgery for people who take daily low-dose aspirin compared to those who don't. It aims to help doctors make safer decisions about aspirin use before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are scheduled for a planned (non-emergency) surgery to clip a brain aneurysm.
- You are either taking a daily low-dose aspirin (75–100 mg) or you have not taken any aspirin for at least 7 days before surgery.
- You have not used other blood thinners (like warfarin or clopidogrel) within 7 days before surgery.
- You do not have a bleeding disorder (like hemophilia or low platelets).
- You have not had a brain bleed unrelated to your aneurysm in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving aspirin early after a ruptured brain aneurysm is treated can help prevent complications like vasospasm (a narrowing of brain blood vessels) and improve recovery. It is for people who have already had the aneurysm secured within 48 hours.
This trial tests if taking aspirin before and after a procedure to fix an unruptured brain aneurysm (coiling) helps prevent complications. Aspirin is a common blood thinner that might reduce the risk of blood clots or other problems after the procedure.
This study compares two common blood-thinner combinations to see which one works better at preventing clots during stent placement for an unruptured brain aneurysm. It is designed for people whose bodies process these medications normally, with the goal of finding the safest and most effective option.
This trial looks at whether people with a chronic subdural hematoma (a slow bleed on the brain) who are not having surgery should keep taking aspirin or stop it. It aims to find out which approach is safer and helps the hematoma heal better.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This study is for people admitted with a confirmed brain bleeding caused by a ruptured aneurysm. The goal is to better understand this specific cause of bleeding, which may help improve care for patients with aneurysm-related subarachnoid hemorrhage.
Hear when a new Aneurysm Cerebral trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.